News

/News/

Joint Press Announcement: RPS Diagnostics partners with Atomo Diagnostics

RPS Diagnostics partners with Atomo Diagnostics to develop next generation FebriDx blood tests for antibiotic stewardship in the outpatient setting Sarasota, Florida and Sydney, Australia (February 20, 2018) – United [...]

February 20th, 2018|

New partnership anticipated to transform the diagnosis of febrile ARIs at the point-of-care

Atomo Diagnostics is delighted to announce it's commercial and development partnership with US biotechnology company, RPS Diagnostics. In a joint Press Announcement, the companies have shared plans to create next generation FebriDx® [...]

February 20th, 2018|

Strategic Partnership Announcement: Atomo Diagnostics and Access Bio

Today, Atomo Diagnostics and Access Bio Inc. jointly announced a strategic partnership to leverage the respective strengths of both companies and expand point of care HIV testing in global markets. [...]

January 23rd, 2018|

Atomo Diagnostics and Access Bio partner to expand access to best-in-class HIV rapid testing in global markets

Sydney, Australia and Seoul, South Korea – 23 January 2018 | Atomo Diagnostics and Access Bio Inc. today announce a strategic partnership to leverage the respective strengths of both innovative [...]

January 23rd, 2018|

Atomo HIV Self Test approved by Expert Review Panel

Atomo Diagnostics' CEO, John Kelly, today announced that the Atomo HIV Self Test has been approved by the World Health Organisation’s Expert Review Panel for Diagnostics (ERP-D); a special process determined [...]

December 6th, 2017|

PRESS RELEASE: Expert Review Panel for Diagnostics approves Atomo HIV Self Test for procurement by Unitaid and the Global Fund

Sydney, Australia, 7 December 2017 | Atomo Diagnostics, the world leader in integrated point-of-care rapid diagnostic devices, announced today that its Atomo HIV Self Test has been confirmed as eligible [...]

December 6th, 2017|

World AIDS Day 2017: Self-testing key to improving early diagnosis of HIV

Written by CEO, John Kelly: As I read the news, on this World AIDS Day, I am heartened to see so many positive and inspiring stories about the progress being [...]

December 1st, 2017|

CE Marking granted for Atomo HIV Self Test

Atomo Diagnostics' CEO John Kelly announced today that the Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body. The company is now actively engaging with commercialisation and distribution [...]

October 10th, 2017|

PRESS RELEASE: CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics gives access to safe, accurate and reliable self-testing

  SYDNEY, AUSTRALIA, October 10, 2017 – Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE [...]

October 10th, 2017|

SAHIVSoc publishes Clinical Guidelines for HIV Self-Testing

Written by John Kelly, CEO at Atomo Diagnostics: The Southern African HIV Clinicians Society (SAHIVSoc) has recently published it's clinical guidelines for HIV self-testing to support achieving the first '90' of [...]

June 19th, 2017|